Below are the most recent publications written about "Pyrrolidines" by people in Profiles.
-
Jaykumar AB, Jung JU, Parida PK, Dang TT, Wichaidit C, Kannangara AR, Earnest S, Goldsmith EJ, Pearson GW, Malladi S, Cobb MH. WNK1 Enhances Migration and Invasion in Breast Cancer Models. Mol Cancer Ther. 2021 10; 20(10):1800-1808.
-
Pan N, Rao W, Standke SJ, Yang Z. Using Dicationic Ion-Pairing Compounds To Enhance the Single Cell Mass Spectrometry Analysis Using the Single-Probe: A Microscale Sampling and Ionization Device. Anal Chem. 2016 07 05; 88(13):6812-9.
-
Patkar KA, Wu J, Ganno ML, Singh HD, Ross NC, Rasakham K, Toll L, McLaughlin JP. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on ?-opioid receptors. J Pharmacol Exp Ther. 2013 Sep; 346(3):545-54.
-
Shankar R, Chakravarti B, Singh US, Ansari MI, Deshpande S, Dwivedi SK, Bid HK, Konwar R, Kharkwal G, Chandra V, Dwivedi A, Hajela K. Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem. 2009 Jun 01; 17(11):3847-56.
-
Lamanna C, Catalano A, Carocci A, Di Mola A, Franchini C, Tortorella V, Vanderheyden PM, Sinicropi MS, Watson KA, Sciabola S. AT1 receptor ligands: virtual-screening-based design with TOPP descriptors, synthesis, and biological evaluation of pyrrolidine derivatives. ChemMedChem. 2007 Sep; 2(9):1298-310.
-
Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol. 2006 Oct; 291(4):H1694-9.
-
Brouillette WJ, Bajpai SN, Ali SM, Velu SE, Atigadda VR, Lommer BS, Finley JB, Luo M, Air GM. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents. Bioorg Med Chem. 2003 Jul 03; 11(13):2739-49.
-
Xia L, Pan J, Yao L, McEver RP. A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood. 1998 Mar 01; 91(5):1625-32.
-
Sharma MK, Voyles W, Prasad R, Teague SM, Thadani U. Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3.
-
Shapiro W, DiBianco R, Thadani U. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C.